Sequence analysis of the HBV S protein in Chinese patients with coexisting HBsAg and anti-HBs antibodies. 2015

Feng Ding, and Hong-Gang Yu, and Yan-Xia Li, and Ning Cui, and Jin-Fen Dai, and Jie-Ping Yu
Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, P.R. China.

The coexistence of hepatitis B surface antigen (HBsAg) and antibodies to HBsAg (anti-HBs) in patients with hepatitis B virus (HBV) infection has been discovered and explained for several decades, but debate still exists. This study was to explore the relationship between this special serological pattern and mutations in S gene region. Fifteen patients with coexisting HBsAg and anti-HBs were selected as the experimental group, and 27 patients with HBsAg positive only were selected as the control group. The S gene region was amplified and sequenced. No significant differences were observed between the two groups with regard to age, gender, alanine aminotransferase level, HBsAg titer, genotype, and HBV DNA level. The patients from the two groups were infected with HBV of the genotype B and C. Compared with the control group, the experimental group showed a higher variability in amino acid within the N-terminal region and the MHR, especially the "a" determinant. The most frequent change in patients from the experimental group was located at positions s126. The coexistence of HBsAg and anti-HBs might be associated with the increased amino acid mutations in the "a" determinant. Further studies should be performed to determine the clinical implication of this serological pattern, including the binding of anti-HBs to HBsAg, escape from immune system, and efficacy of antiviral therapy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Feng Ding, and Hong-Gang Yu, and Yan-Xia Li, and Ning Cui, and Jin-Fen Dai, and Jie-Ping Yu
November 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
Feng Ding, and Hong-Gang Yu, and Yan-Xia Li, and Ning Cui, and Jin-Fen Dai, and Jie-Ping Yu
January 1995, Przeglad epidemiologiczny,
Feng Ding, and Hong-Gang Yu, and Yan-Xia Li, and Ning Cui, and Jin-Fen Dai, and Jie-Ping Yu
April 2017, Scientific reports,
Feng Ding, and Hong-Gang Yu, and Yan-Xia Li, and Ning Cui, and Jin-Fen Dai, and Jie-Ping Yu
January 1996, Medycyna doswiadczalna i mikrobiologia,
Feng Ding, and Hong-Gang Yu, and Yan-Xia Li, and Ning Cui, and Jin-Fen Dai, and Jie-Ping Yu
July 2006, World journal of gastroenterology,
Feng Ding, and Hong-Gang Yu, and Yan-Xia Li, and Ning Cui, and Jin-Fen Dai, and Jie-Ping Yu
January 2008, Human vaccines,
Feng Ding, and Hong-Gang Yu, and Yan-Xia Li, and Ning Cui, and Jin-Fen Dai, and Jie-Ping Yu
January 2021, International journal of biological sciences,
Feng Ding, and Hong-Gang Yu, and Yan-Xia Li, and Ning Cui, and Jin-Fen Dai, and Jie-Ping Yu
August 2018, Journal of viral hepatitis,
Feng Ding, and Hong-Gang Yu, and Yan-Xia Li, and Ning Cui, and Jin-Fen Dai, and Jie-Ping Yu
November 2018, International journal of molecular medicine,
Feng Ding, and Hong-Gang Yu, and Yan-Xia Li, and Ning Cui, and Jin-Fen Dai, and Jie-Ping Yu
January 1992, Journal of immunological methods,
Copied contents to your clipboard!